Shortage of Penicillin G Benzathine Injection

What's in Shortage

The generic drug Penicillin G Benzathine Injection, with brand name BICILLIN L-A, is in a current shortage. It is available in injection dosage form and belongs to the therapeutic category of Anti-Infective. The shortage status is current, with the initial posting date of 04/26/2023 and last updated on 03/27/2026.

Which Manufacturers Are Affected

The affected manufacturer is Pfizer Inc., which has limited availability for the following presentations:

• Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10): Limited Availability. Related info: Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay. Contact info: 844-646-4398
• Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10): Limited Availability. Related info: Next Delivery: October 2027; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay. Contact info: 844-646-4398
• Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10): Limited Availability. Related info: Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay. Contact info: 844-646-4398

Why There's a Shortage

The reason for the shortage is listed as "Other." Manufacturer-specific notes indicate a Manufacturing Delay.

What Patients Should Do

Patients who depend on this medication should talk to their pharmacist or healthcare provider about the current availability and options. They can also contact the manufacturer for more details. Please remember that patients should consult their healthcare provider for any guidance and not make changes to their treatment plan without professional advice.

Source

This information is attributed to the FDA Drug Shortage Database.